Evaluation of anticonvulsant-induced bone changes by a microdensitometric method
Iwata, Y.; Amano, K.; Kawamura, H.; Tanikawa, T.; Kawabatake, H.; Notani, M.; Iseki, H.; Shiwaku, T.; Nagao, T.; Taira, T.
No Shinkei Geka. Neurological Surgery 13(3): 293-299
1985
ISSN/ISBN: 0301-2603 PMID: 4010879 Document Number: 256565
The effect of long-term anticonvulsants on bone change was evaluated by microdensitometric method (MD method) in 221 outpatients of Neurological Institute Tokyo Women's Medical College. Laboratory findings including serum Ca, P, Al-p were compared with severity of bone change. Following results were obtained. In 221 patients, 159 cases (72%) were normal, 31 cases (14%) were in the initial stage of abnormality, 23 cases (10%) in grade I, 7 cases (3%) in grade II and 1 case (1%) in grade III of abnormality. Incidence of abnormality was high in the group of 26-35 yr old and in the age over 56 yr old. Total dose, serum concentration of diphenylhydantoin (DPH) as well as phenobarbital (PB) and also duration of administration of PB correlated positively with severity of bone change. Duration of administration of DPH and valproic acid (VPA), total dose and serum concentration of VPA did not correlate with severity of bone change. Serum Ca correlated with severity of bone change, but P and Al-p did not correlate with severity of bone change. Pattern of bone change was estimated by 2 parameters of MD method (MCI and GSmax). Results showed that most of the osteopathy (grade I-III by MD method) fell into osteoporotic type. It is suggested that roentgenologic and biochemical supervision of the patients is required during long-term anticonvulsant therapy.